ID

35010

Beschrijving

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02338115

Link

https://clinicaltrials.gov/show/NCT02338115

Trefwoorden

Versies (1)
  1. 08-02-19 08-02-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

8 februari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT02338115

Engels

Eligibility Breast Cancer NCT02338115

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of invasive breast cancer
Beschrijving

Invasive carcinoma of breast

Datatype

boolean

Alias
UMLS CUI [1]
C0853879
systemic treatment with paclitaxel for curative intent (neoadjuvant, adjuvant, or oligometastatic disease per pi discretion)
Beschrijving

Paclitaxel | Systemic therapy Curative | Neoadjuvant Therapy Disease | Adjuvant therapy Disease | Neoplasm Metastasis Few

Datatype

boolean

Alias
UMLS CUI [1]
C0144576
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C1276305
UMLS CUI [3,1]
C0600558
UMLS CUI [3,2]
C0012634
UMLS CUI [4,1]
C0677850
UMLS CUI [4,2]
C0012634
UMLS CUI [5,1]
C0027627
UMLS CUI [5,2]
C0205388
80 mg/m2 1-hour infusions weekly for up to 12 weeks
Beschrijving

Infusions U/week

Datatype

boolean

Alias
UMLS CUI [1,1]
C0574032
UMLS CUI [1,2]
C0560588
female sex
Beschrijving

Gender

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
>18 years old
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
ability to understand and the willingness to sign a written informed consent.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
any prior or concurrent treatment with neurotoxic chemotherapy including any taxane, vinca alkaloid, platinum, bortezomib, or thalidomide. note that concurrent biologic treatment with trastuzumab/pertuzumab for her2+ patients or prior treatment with adriamycin/cyclophosphamide are not reasons for exclusion.
Beschrijving

Chemotherapy Neurotoxic agents | taxane | Vinca Alkaloids | Platinum | bortezomib | Thalidomide

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0260049
UMLS CUI [2]
C0215136
UMLS CUI [3]
C0042672
UMLS CUI [4]
C0032207
UMLS CUI [5]
C1176309
UMLS CUI [6]
C0039736
distant metastatic disease
Beschrijving

Distant metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C1269798
concurrent treatment with duloxetine or enrollment on clinical study of neuroprotective agent
Beschrijving

duloxetine | Study Subject Participation Status | Neuroprotective Agents

Datatype

boolean

Alias
UMLS CUI [1]
C0245561
UMLS CUI [2]
C2348568
UMLS CUI [3]
C0242912
history of allergic reaction to paclitaxel or cremophor el
Beschrijving

Paclitaxel allergy | Hypersensitivity Cremophor EL

Datatype

boolean

Alias
UMLS CUI [1]
C0570707
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0056476
current signs or symptoms of severe peripheral neuropathy
Beschrijving

Sign or Symptom Peripheral Neuropathy Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0031117
UMLS CUI [1,3]
C0205082
known family history of hereditary peripheral neuropathy or charcot-marie-tooth disease
Beschrijving

Family history Hereditary peripheral neuropathy | Family history of Charcot-Marie-Tooth disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0241889
UMLS CUI [1,2]
C0392553
UMLS CUI [2]
C2316866
known current pregnancy
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT02338115

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
diagnosis of invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Paclitaxel | Systemic therapy Curative | Neoadjuvant Therapy Disease | Adjuvant therapy Disease | Neoplasm Metastasis Few
Item
systemic treatment with paclitaxel for curative intent (neoadjuvant, adjuvant, or oligometastatic disease per pi discretion)
boolean
C0144576 (UMLS CUI [1])
C1515119 (UMLS CUI [2,1])
C1276305 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0677850 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0027627 (UMLS CUI [5,1])
C0205388 (UMLS CUI [5,2])
Infusions U/week
Item
80 mg/m2 1-hour infusions weekly for up to 12 weeks
boolean
C0574032 (UMLS CUI [1,1])
C0560588 (UMLS CUI [1,2])
Gender
Item
female sex
boolean
C0079399 (UMLS CUI [1])
Age
Item
>18 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Neurotoxic agents | taxane | Vinca Alkaloids | Platinum | bortezomib | Thalidomide
Item
any prior or concurrent treatment with neurotoxic chemotherapy including any taxane, vinca alkaloid, platinum, bortezomib, or thalidomide. note that concurrent biologic treatment with trastuzumab/pertuzumab for her2+ patients or prior treatment with adriamycin/cyclophosphamide are not reasons for exclusion.
boolean
C0392920 (UMLS CUI [1,1])
C0260049 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2])
C0042672 (UMLS CUI [3])
C0032207 (UMLS CUI [4])
C1176309 (UMLS CUI [5])
C0039736 (UMLS CUI [6])
Distant metastasis
Item
distant metastatic disease
boolean
C1269798 (UMLS CUI [1])
duloxetine | Study Subject Participation Status | Neuroprotective Agents
Item
concurrent treatment with duloxetine or enrollment on clinical study of neuroprotective agent
boolean
C0245561 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C0242912 (UMLS CUI [3])
Paclitaxel allergy | Hypersensitivity Cremophor EL
Item
history of allergic reaction to paclitaxel or cremophor el
boolean
C0570707 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0056476 (UMLS CUI [2,2])
Sign or Symptom Peripheral Neuropathy Severe
Item
current signs or symptoms of severe peripheral neuropathy
boolean
C3540840 (UMLS CUI [1,1])
C0031117 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Family history Hereditary peripheral neuropathy | Family history of Charcot-Marie-Tooth disease
Item
known family history of hereditary peripheral neuropathy or charcot-marie-tooth disease
boolean
C0241889 (UMLS CUI [1,1])
C0392553 (UMLS CUI [1,2])
C2316866 (UMLS CUI [2])
Pregnancy
Item
known current pregnancy
boolean
C0032961 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial